|1.||Huang, Chih-Yang: 2 articles (02/2012 - 03/2006)|
|2.||Wyatt, Jarrett E: 1 article (01/2015)|
|3.||Whitted, Crystal: 1 article (01/2015)|
|4.||LeJeune, Timothy M: 1 article (01/2015)|
|5.||Livesay, Christopher: 1 article (01/2015)|
|6.||Parsons, Laura B: 1 article (01/2015)|
|7.||Pilchova, Ivana: 1 article (01/2015)|
|8.||Lynch, Kayla E: 1 article (01/2015)|
|9.||Tatarkova, Zuzana: 1 article (01/2015)|
|10.||Miller, Gerald E: 1 article (01/2015)|
|1.||Stomach Neoplasms (Stomach Cancer)
07/01/2008 - "High expression of the Bad protein [hazard ratio (HR), 0.64; 95% confidence interval (95% CI), 0.43-0.96; P = 0.031] in the cytoplasm of tumor cells was significantly associated with more favorable OS in a univariate analysis. "
01/01/1998 - "Taken together, these findings define for the first time the normal cell-type-specific patterns of expression and intracellular locations of the BAD protein in vivo and provide insights into the regulation of this pro-apoptotic Bcl-2 family protein in human tumors."
10/01/2005 - "The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells."
01/01/1998 - "The BAD protein derived from 11 of 41 tumor lines that expressed this pro-apoptotic protein migrated in gels as a clear doublet, consistent with the presence of hyperphosphorylated BAD protein. "
08/01/2007 - "Immunohistochemical analysis of phospho-BAD protein and mutational analysis of BAD gene in gastric carcinomas."
03/01/2013 - "It also induced the apoptosis of human pancreatic carcinoma cells in vitro by decreasing the levels of phospho-Ser112-Bad; the levels of Pim-3 kinase and total Bad protein were not altered. "
12/10/2010 - "Using the human gastric carcinoma cell line AGS we show that CTFP attenuates apoptosis through a PI3-kinase pathway by stimulating the phosphorylation of Akt leading to sustained increases in the concentrations of Bcl-xL and phosphorylated Bad protein and by reducing caspase 3 activity. "
|4.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2012 - "Recently, it has been demonstrated that the phosphorylation status of the BCL2 antagonist of cell death (BAD) protein may influence ovarian cancer (OVCA) cell sensitivity to cisplatin. "
09/01/2000 - "BAD protein, b-myb), and novel potential markers of ovarian cancer, such as cofilin, moesin, and neuron-restrictive silencer factor (REST) protein. "
01/01/2015 - "However, significantly elevated level of Bad protein in the mitochondria isolated from rat hippocampus was observed already 1 h after ischemia and remained elevated 3 and 24 h after ischemia. "
05/15/2002 - "Consistent with these effects, the ischemia-induced increase in Bad protein level and caspase-3 activation were suppressed in TGF-beta1-transduced brain. "
|2.||Caspase 3 (Caspase-3)
|3.||Histone Deacetylase Inhibitors
|4.||bcl-2-Associated X Protein (bcl 2 Associated X Protein)
|6.||Apoptosis Regulatory Proteins